What next for a COVID-19 intellectual property waiver?
作者信息
Zarocostas John
出版信息
Lancet. 2021 May 22;397(10288):1871-1872. doi: 10.1016/S0140-6736(21)01151-X.
Abstract
摘要
相似文献
1
What next for a COVID-19 intellectual property waiver?新冠病毒知识产权豁免接下来会怎样？
Lancet. 2021 May 22;397(10288):1871-1872. doi: 10.1016/S0140-6736(21)01151-X.
2
A patent waiver on COVID vaccines is right and fair.新冠疫苗专利豁免是正确且公平的。
Nature. 2021 May;593(7860):478. doi: 10.1038/d41586-021-01242-1.
3
Ensuring fair distribution of COVID-19 vaccines: is an intellectual waiver the answer?确保新冠疫苗的公平分配：知识共享豁免是答案吗？
Lancet Respir Med. 2021 Jul;9(7):e64. doi: 10.1016/S2213-2600(21)00241-1. Epub 2021 May 21.
4
Intellectual property waiver for covid-19 vaccines will advance global health equity.新冠疫苗的知识产权豁免将推动全球卫生公平。
BMJ. 2021 Aug 3;374:n1837. doi: 10.1136/bmj.n1837.
5
Pool patents to get COVID vaccines and drugs to all.集中专利，让所有人都能获得新冠疫苗和药物。
Nature. 2021 Mar;591(7851):529. doi: 10.1038/d41586-021-00759-9.
6
[Access to anti-covid vaccines: research, development and role of patents.].[获得抗新冠疫苗：专利的研究、开发及作用。]
Recenti Prog Med. 2021 Jul-Aug;112(7):499-503. doi: 10.1701/3638.36184.
7
A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.全球知识产权豁免仍有必要，以解决新冠肺炎和未来大流行防范的不公平问题。
Inquiry. 2022 Jan-Dec;59:469580221124821. doi: 10.1177/00469580221124821.
8
Time is running out for COVID vaccine patent waivers.新冠疫苗专利豁免的时间不多了。
Nature. 2022 Mar;603(7903):764. doi: 10.1038/d41586-022-00878-x.
9
Free licensing of vaccines to end the COVID-19 crisis.免费发放疫苗以结束新冠疫情危机。
Lancet. 2021 Apr 3;397(10281):1261-1262. doi: 10.1016/S0140-6736(21)00467-0. Epub 2021 Mar 18.
10
Omicron is bad but the global response is worse.奥密克戎毒株很糟糕，但全球应对措施更糟糕。
Nature. 2021 Dec;600(7888):190. doi: 10.1038/d41586-021-03616-x.
引用本文的文献
1
Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity.全球 COVID-19 疫苗接种计划扩大规模：生产、分配和分发，重点关注公平性。
Yale J Biol Med. 2022 Sep 30;95(3):379-387. eCollection 2022 Sep.
2
Exploring the role of R&D collaborations and non-patent IP policies in government technology transfer performance: Evidence from U.S. federal agencies (1999-2016).探索研发合作和非专利知识产权政策在政府技术转移绩效中的作用：来自美国联邦机构的证据（1999-2016）。
PLoS One. 2022 May 24;17(5):e0268828. doi: 10.1371/journal.pone.0268828. eCollection 2022.
3
Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching.从天主教社会教义的角度分析新冠疫苗专利权的拥有与中止的道德性
Linacre Q. 2022 Feb;89(1):47-63. doi: 10.1177/00243639211050494. Epub 2021 Dec 8.
4
Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?探索针对 SARS-CoV-2 及其变体的 COVID-19 候选疫苗：我们的立场在哪里，我们的前进方向在哪里？
Hum Vaccin Immunother. 2021 Dec 2;17(12):4714-4740. doi: 10.1080/21645515.2021.1995283.
Zotero 插件